Massachusetts Lawmakers Prioritize Health Policy
Katherine O'Malley
August 12, 2026
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Maintaining “under-performing” maternity wards may not be possible — or, more importantly, safe — but closing them reduces access for expectant mothers.
Pregnancy can be a scary time for many reasons, one of which is having so many things feel off-limits for the safety of the fetus.
How can we navigate towards more open access and equity in research?
Malaria kills a lot of people every year, and many of those people are young children. Developing a vaccine against this deadly disease has been
Men and women who inject drugs live with different risks of acquiring infections such as HIV, yet research that assesses gender-specific risks has historically been scarce. Understanding these differences is key to reducing the harms of injection drug use and facilitating effective interventions.
Over at Scotusblog, I’ve posted a recap of yesterday’s oral argument on American Hospital Association v. Becerra. The Supreme Court appeared receptive to the claim
David Haas, MD, returns to the Healthcare Triage podcast to share his research about expecting moms and their babies, including a new study about how
There’s a lot of talk about “natural immunity” to Covid-19, and some people are refusing vaccination on the grounds that they’ve got this natural immunity
Over at SCOTUSblog, I’ve written a case preview for American Hospital Association v. Becerra, which is being argued tomorrow. The case is not only important
I am a patient with recurrent throat cancer and an end-stage diagnosis, although I’m currently in remission. This means that I live in a liminal
Health Services Research (HSR) and The John A. Hartford Foundation are partnering to publish a Special Issue on Age-Friendly Health Systems. Abstract proposals are due November 22, 2021
Molnupiravir is a broad-spectrum antiviral that has been in development for quite some time – it was first tested as an Ebola drug and is